Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
Leonardo Delello Di Filippo, Juliana H. Azambuja, Jessyca Aparecida Paes Dutra, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 168, pp. 76-89
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
Xiao Liu, Zhengcong Cao, Weizhong Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16432-16447
Open Access | Times Cited: 47
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 30
LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF/USP7 axis
Yujie Zhou, Zhen Zhao, Jiang Cheng, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression
Leonardo Delello Di Filippo, Jonatas Lobato Duarte, Juliana H. Azambuja, et al.
International Journal of Pharmaceutics (2022) Vol. 618, pp. 121682-121682
Closed Access | Times Cited: 32
Development, characterization and in vitro cytotoxicity of kaempferol-loaded nanostructured lipid carriers in glioblastoma multiforme cells
Luisa Ribeiro Nicoleti, Leonardo Delello Di Filippo, Jonatas Lobato Duarte, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 226, pp. 113309-113309
Closed Access | Times Cited: 19
Polyhedral Oligomeric Silsesquioxane‐Based Nanoparticles for Efficient Chemotherapy of Glioblastoma
Xiang-Yang Zhong, Gang Wei, Boyang Liu, et al.
Small (2023) Vol. 19, Iss. 18
Closed Access | Times Cited: 17
Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology
Baoqin Song, Xiu Wang, Lijing Qin, et al.
Pharmacological Research (2024) Vol. 206, pp. 107308-107308
Open Access | Times Cited: 7
Cannabinoids in the treatment of glioblastoma
Barbara Buchalska, Katarzyna Kamińska, Maja Owe-Larsson, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 223-234
Closed Access | Times Cited: 5
Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy
Maria João Ramalho, E.T. Serra, Jorge Lima, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114326-114326
Open Access | Times Cited: 5
Brain-targeting redox-sensitive micelles for codelivery of TMZ and β-lapachone for glioblastoma therapy
Yuxiang Dai, Yuanping Min, Zhou Lu, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 61, pp. 102772-102772
Closed Access | Times Cited: 5
Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO2 -nanospheres for the treatment of glioblastoma
Minerva Uribe-Robles, Emma Ortiz-Islas, Citlali Ekaterina Rodríguez-Pérez, et al.
Biomaterials Advances (2023) Vol. 151, pp. 213442-213442
Closed Access | Times Cited: 12
Therapeutic performance of temozolomide-loaded nanomaterials: A state-of-the-art
Mehrab Pourmadadi, Amin Shamsabadipour, A. R. Bhatti, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 85, pp. 104568-104568
Open Access | Times Cited: 12
A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment
Xing Yang, Feroza Yasinjan, Mei Yang, et al.
Nano Today (2023) Vol. 52, pp. 101961-101961
Closed Access | Times Cited: 12
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho, Jonatas Lobato Duarte, et al.
Materials Today Bio (2023) Vol. 20, pp. 100671-100671
Open Access | Times Cited: 11
MicroRNA biosensors for detection of glioblastoma
Mehdi Fattahi, Mohadese Maghsudlu, Masoumeh Razipour, et al.
Clinica Chimica Acta (2024) Vol. 556, pp. 117829-117829
Closed Access | Times Cited: 4
ADAR1 Promotes the Progression and Temozolomide Resistance of Glioma Through p62‐Mediated Selective Autophagy
Yuyan Zhang, Huiling Guo, Jiahao Bu, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access
Fabrication of temozolomide-loaded polydopamine-coated copper ferrite clocked bovine serum albumin nanoparticles delivery for glioma cancer and induction of apoptosis mechanism
Can Zhu, Huaming Chen, Ziyu Chen, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106642-106642
Closed Access
Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future
Mandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Cancer Letters (2025), pp. 217601-217601
Closed Access
Bioinformatics analysis to identify key invasion related genes and construct a prognostic model for glioblastoma
Jintao Tian, Jinxi Zhao, Zhixing Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Identification of RASL11A as a gene conferring radiosensitivity in glioblastoma
Ruilong Lan, Na Zhang, Ruiqing Chen, et al.
Journal of Neuro-Oncology (2025)
Closed Access
Self-Assembled systems for Nose-to-Brain delivery of Temozolamide (TMZ) in brain tumor therapy
Nishank Bhagat, Zainab Nalawala, J. C. Patel, et al.
International Journal of Pharmaceutics (2025), pp. 125540-125540
Closed Access
Lipid nanoparticles for treatment of glioblastoma multiforme: current status of research and clinical translation
Mugdha Kulkarni, Karthik Nadendla, Ananth Pai, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106891-106891
Open Access
Effectively α-Terpineol Suppresses Glioblastoma Aggressive Behavior and Downregulates KDELC2 Expression
Jong‐Shiaw Jin, Jung-Mao Chou, Wen‐Chiuan Tsai, et al.
Phytomedicine (2024) Vol. 127, pp. 155471-155471
Closed Access | Times Cited: 3
Folic acid‐decorated astrocytes‐derived exosomes enhanced the effect of temozolomide against glioma
Hong‐Ming Liu, Ye Zhang
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 5, pp. 435-444
Open Access | Times Cited: 3
Biomimetic nanocarriers loaded with temozolomide by cloaking brain-targeting peptides for targeting drug delivery system to promote anticancer effects in glioblastoma cells
Huaming Chen, Yunhong Wang, Hai Wang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28256-e28256
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top